Monoclonal Antibody News and Research

RSS
Monoclonal antibodies (MAbs) are produced from a single B cell clone and can bind to a single type of antigen binding site. MAbs are homogenous antibodies that cannot form lattices with monomeric proteins as they can bind to only a single epitope on the antigen. Developed in the 1970s, MAbs can be produced against any given substance. Thus they can be used to detect and purify any substance of interest. This has made MAbs a powerful tool of molecular biology, biochemistry, and medicine.
Analysis shows Remicade reduces pain associated with Crohn's disease

Analysis shows Remicade reduces pain associated with Crohn's disease

Radiotherapy with cetuximab significantly improves disease control and survival in head and neck cancer

Radiotherapy with cetuximab significantly improves disease control and survival in head and neck cancer

Acne-like rash linked to effectiveness of new targeted cancer treatment – cetuximab

Acne-like rash linked to effectiveness of new targeted cancer treatment – cetuximab

New combination of drugs results in fewer incidences of rejection in liver transplant patients

New combination of drugs results in fewer incidences of rejection in liver transplant patients

Elan and Wyeth receive patents for Alzheimer's disease treatments

Elan and Wyeth receive patents for Alzheimer's disease treatments

Mighty mouse helps researchers tackle osteoporosis

Mighty mouse helps researchers tackle osteoporosis

Phase I clinical trial of new drug for severe asthma

Phase I clinical trial of new drug for severe asthma

More women are surviving advanced breast cancer

More women are surviving advanced breast cancer

Phase 1 clinical trial of new anticancer drug from Human Genome Sciences

Phase 1 clinical trial of new anticancer drug from Human Genome Sciences

Signet Laboratories has announced the release of ACUITY mouse-on-mouse polymer detection system

Signet Laboratories has announced the release of ACUITY mouse-on-mouse polymer detection system

New glycan arrays discover autoimmunogenic activities of SARS-CoV

New glycan arrays discover autoimmunogenic activities of SARS-CoV

Women with a history of cancer in their family are better off having MRI scans instead of mammograms

Women with a history of cancer in their family are better off having MRI scans instead of mammograms

Several key findings from clinical trial of an investigational Alzheimer's disease treatment

Several key findings from clinical trial of an investigational Alzheimer's disease treatment

Erbitux (cetuximab) combined with irinotecan offers another option for patients who have colorectal cancer

Erbitux (cetuximab) combined with irinotecan offers another option for patients who have colorectal cancer

Strategic analysis of the breast cancer therapeutics pipeline

Strategic analysis of the breast cancer therapeutics pipeline

New imaging agent will enable doctors to rapidly and accurately detect those hard-to-diagnose appendicitis cases

New imaging agent will enable doctors to rapidly and accurately detect those hard-to-diagnose appendicitis cases

Oxford Therapeutic Antibody Centre receives Manufacturer’s Authorisation

Oxford Therapeutic Antibody Centre receives Manufacturer’s Authorisation

Chemotherapy agents as well as the newest biologic and targeted cancer therapy drugs, can harm a patient’s heart

Chemotherapy agents as well as the newest biologic and targeted cancer therapy drugs, can harm a patient’s heart

Animal vaccine shows potential for the development of human SARS immunisation

Animal vaccine shows potential for the development of human SARS immunisation

University of Cambridge to generate antibodies

University of Cambridge to generate antibodies